About Praesidia Biotherapeutics
Praesidia Biotherapeutics is a private company based in Arlington, Massachusetts, incorporated in 2021 in Delaware. It has reported $7,420,000 raised in one offering on Form D since April 2024. Its chief executive is Sohang Chatterjee.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Mar 25, 2024 | Apr 8, 2024amended Jul 17, 2024 | $7,420,000of $15.0M target | 52 | $142K | Securities on exerciseRule 506(b) | Form D/A ↗2 earlier filings |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Praesidia Biotherapeutics's Form D filed Jul 17, 2024.
SC
Sohang Chatterjee
Chief Executive Officer and director
ST
PM
Pradip Majumder
Executive officer
ML
Martin Lehr
Director
Earlier filings also listed John Ripple (director, last listed Aug 2022).